25I-NBOH

From Food & Medicine Encyclopedia

Revision as of 20:06, 11 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

25I-NBOH
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


25I-NBOH is a synthetic psychedelic compound that belongs to the NBOH series of phenethylamines. It is a derivative of the 2C family of psychedelic phenethylamines, specifically related to 2C-I.

Chemical structure and properties

25I-NBOH is chemically known as 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-hydroxyphenyl)methyl]ethanamine. It features a phenethylamine core with a methoxy group at the 2 and 5 positions and an iodine atom at the 4 position of the phenyl ring. The NBOH series is characterized by the presence of a hydroxybenzyl group attached to the nitrogen atom.

Pharmacology

25I-NBOH acts as a potent agonist at the 5-HT2A receptor, which is the primary target for classical psychedelics. This receptor is a subtype of the serotonin receptor family and is involved in the modulation of mood, perception, and cognition. The activation of 5-HT2A receptors by 25I-NBOH is responsible for its psychedelic effects.

Effects

The effects of 25I-NBOH are similar to those of other psychedelics, such as LSD and psilocybin. Users report altered visual and auditory perceptions, changes in thought patterns, and an altered sense of time. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.

Legal status

The legal status of 25I-NBOH varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. In others, it may be unscheduled but subject to analogue laws that regulate substances similar to controlled drugs.

Safety and toxicity

There is limited information on the safety and toxicity of 25I-NBOH. As with other research chemicals, the lack of comprehensive studies means that the long-term effects and potential risks are not well understood. Users should exercise caution and be aware of the potential for adverse reactions.

Related pages

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.